Synlett 2006(13): 2151-2153  
DOI: 10.1055/s-2006-948184
LETTER
© Georg Thieme Verlag Stuttgart · New York

A Mitsunobu Diol Cyclisation to Chiral Morpholines and Dioxanes

Mark C. Wilkinson*, Rebecca Bell, Robert Landon, Petar O. Nikiforov, Andrew J. Walker
GlaxoSmithKline, Chemical Development, Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK
Fax: +44(1438)764869; e-Mail: Mark.C.Wilkinson@GSK.com;
Weitere Informationen

Publikationsverlauf

Received 6 March 2006
Publikationsdatum:
09. August 2006 (online)

Abstract

A diol cyclisation under Mitsunobu conditions is presented, which allows access to chiral substituted morpholines and dioxanes.

    References

  • 1 Ancliff RA, Cook CM, Eldred CD, Gore PM, Harrison LA, Hayes MA, Hodgson ST, Judd DB, Keeling SE, Lewell XQ, Mills G, Robertson GM, Swanson S, Walker AJ, and Wilkinson M. inventors; PCT Int. Appl. WO  2003082861.  ; Chem. Abstr. 2003, 139, 307777
  • 2 Kato S. Morie T. Hino K. Kon T. Naruto S. Yoshida N. Karasawa T. Matsumoto J.-I. J. Med. Chem.  1990,  33:  1406 
  • 3 Loftus F. Synth. Commun.  1980,  10:  59 
  • 4 Chiral morpholine synthesis via tosylation, see: Myers AG. Lanman BA. Org. Lett.  2004,  6:  1045 
  • 5 Hayes MA, Mills G, Swanson S, Walker AJ, and Wilkinson M. inventors; PCT Int. Appl. WO  2003082835.  ; Chem. Abstr. 2003, 139, 307774
  • 6 For other routes, see: Wilkinson MC. Tetrahedron Lett.  2005,  46:  4773